Physician profile
James A Weeks
NPI 1114992104
$2,928.35
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $515 · 2021: $885 · 2022: $914 · 2023: $28.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $316.50 | 2019-2022 | |
| Pfizer INC. | $290.89 | 2019-2022 | |
| Amgen INC. | $290.37 | 2019-2023 | Prolia, Evenity |
| Janssen Pharmaceuticals, INC | $279.75 | 2019-2022 | |
| Lilly USA, LLC | $212.33 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $207.20 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $201.02 | 2021-2022 | |
| Abbvie INC. | $198.74 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $105.08 | 2019-2022 | |
| Allergan, INC. | $90.27 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $78.92 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $66.33 | 2020-2022 | |
| Daiichi Sankyo INC. | $64.53 | 2020-2022 | |
| Sanofi Pasteur INC. | $62.99 | 2019-2022 | |
| Eisai INC. | $56.79 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $43.22 | 2019-2022 | |
| Optinose US, INC. | $34.83 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $33.22 | 2021 | |
| Nestle Healthcare Nutrition INC. | $29.62 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.32 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $22.32 | 2021 | |
| Alexion Pharmaceuticals, INC. | $22.31 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $21.27 | 2021 | |
| Organon LLC | $20.11 | 2022 | |
| Medtronic, INC. | $18.57 | 2021 | |
| Corium, LLC | $18.08 | 2022 | |
| Hologic Sales and Service, LLC | $17.18 | 2021 | |
| Therapeuticsmd, INC. | $15.99 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.95 | 2020 | |
| Philips North America LLC | $13.81 | 2019 | |
| Novo Nordisk INC | $13.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.30 | 2020 | |
| Jazz Pharmaceuticals INC. | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Weeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.